87425805 - L

Information

• Trademark
• 87425805

• Source

• Serial Number

  87425805

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  April 26, 2017
  7 years ago

• Transaction Date

  January 29, 2018
  7 years ago

• Status Date

  January 27, 2018
  7 years ago

• Published for Opposition Date

  September 19, 2017
  7 years ago

• Location Date

  January 27, 2018
  7 years ago

• Status Code

  604

• Current Location

  TTAB

  Employee Name

  KEELEY, ALISON REBECCA

• Attorney Name

  Timothy T. Wang

  Law Office Assigned Location Code

  L40

• Owners

  • SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of a hexagon or cube shape formed by three L shapes of equal size. The top and bottom-right L shapes form an outward point, with the bottom-left L shape flipped, with the point going inward.
• GS0051: Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
• PM0001: LLL
• PM0002: L L L

Case File Event Statements

• 1/29/2018 - 7 years ago

  18 - ABANDONMENT NOTICE MAILED - INTER PARTES DECISION Type: MAB4

• 1/27/2018 - 7 years ago

  17 - ABANDONMENT - AFTER INTER PARTES DECISION Type: ABN4

• 1/27/2018 - 7 years ago

  16 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 1/27/2018 - 7 years ago

  15 - OPPOSITION SUSTAINED NO. 999999 Type: OP.S

• 10/19/2017 - 7 years ago

  14 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 10/19/2017 - 7 years ago

  13 - OPPOSITION PAPERS RECEIVED AT TTAB Type: OPPF

• 9/19/2017 - 7 years ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/19/2017 - 7 years ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/30/2017 - 7 years ago

  10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/27/2017 - 7 years ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/27/2017 - 7 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 7/27/2017 - 7 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 7/27/2017 - 7 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 7/27/2017 - 7 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/24/2017 - 7 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/4/2017 - 7 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/3/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 4/29/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP